Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Hematology
Description:
Welcome to today’s episode. We’re exploring how AI is transforming blood transfusion safety, specifically by predicting delayed hemolytic transfusion reactions, or DHTRs. These reactions happen when a patient’s immune system attacks transfused red blood cells days or weeks after a transfusion. Using donor-recipient antigen exposure modeling, AI can analyze detailed blood group data from both donor and recipient. By identifying mismatches in minor blood group antigens, the model predicts the risk of DHTRs before transfusion occurs. This proactive approach helps physicians select the best-matched blood, reducing complications and improving patient care. As this technology advances, we can expect safer transfusions and better outcomes for patients worldwide.
See More Webinars @ Hidoc Webinars
1.
ALK-positive lung cancer trial results show unprecedented progression-free survival.
2.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
3.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
4.
Study Finds Microplastics Near Tumors; Experts Doubt Results
5.
Pollution exposure may affect lung cancer in women who have never smoked
1.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
2.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
3.
Prognostic Trajectories of Functional Recovery Following Major Hematologic Disorders
4.
Progressive Perspectives in Oncology Across Clinical Settings
5.
Digital Oncology Navigation Systems for Coordinated Multidisciplinary Cancer Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
3.
Evidence-Based Oncology
4.
Screening for Red Cell Membrane Disorders Through Ektacytometry-Based Deformability Profiling
5.
Oropharyngeal Cancer in Relation to HPV Status
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge